TCR2 Therapeutics Inc (NASDAQ:TCRR)

1.43
Delayed Data
As of Feb 03
 0.00 / 0.00%
Today’s Change
0.82
Today|||52-Week Range
3.88
+43.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2017
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization76.0K116.0K135.0K--
 
 
 
 
 
Operating ExpensesGross Income-76.0K-116.0K-135.0K0.00
 
 
 
 
General Expenses4.0M8.3M10.6M12.1M
 
 
 
 
 
Research And Development2.7M6.1M7.8M8.8M
 
 
 
 
 
Total Operating Expenses4.0M8.4M10.8M12.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.0M-8.4M-10.8M-12.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.0M-7.7M-9.9M-11.1M
 
 
 
 
 
Preferred Dividend-522.0K-3.7M-49.9M0.00
 
 
 
 
Net Income-4.0M-7.7M-9.9M-11.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.9M23.9M12.3M23.8M
 
 
 
 
 
Shares To Calculate EPS Diluted23.9M23.9M12.3M23.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.19-$0.48-$4.85-$0.46
 
 
 
 
 
EPS Diluted-$0.19-$0.48-$4.85-$0.46